You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse-Remitting Multiple Sclerosis (RR-MS)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Glostrup, Copenhagen, Denmark
  • +11 more
May 3, 2022

MS - a Prospective Cohort Study

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
  • PASS-MS
  • Berlin, Germany
    Experimental and Clinical Research Center, Studienambulanz Neuro
Aug 9, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Iran, Islamic Republic of (Ocrelizumab (CinnaGen, Iran), Ocrelizumab (Roche,

Active, not recruiting
  • Multiple Sclerosis
  • Relapsing-Remitting
  • Ocrelizumab (CinnaGen, Iran)
  • Ocrelizumab (Roche, Switzerland)
  • Rasht, Guilan, Iran, Islamic Republic of
  • +14 more
Aug 31, 2021

Relapsing Remitting Multiple Sclerosis Trial in Netherlands (Personalized extended interval dosing of natalizumab, Standard

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Personalized extended interval dosing of natalizumab
  • Standard interval dosing
  • Almelo, Netherlands
  • +23 more
Sep 22, 2021

Interferon Beta-1a on Changes of Non-conventional MRI Measures

Completed
  • Multiple Sclerosis
  • Avonex® monotherapy (6.0 MIU administered i.m. each week)
  • Buffalo, New York
    The Jacobs Neurological Institute
Dec 23, 2020

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (IMU-838 tablets, Placebo matching IMU-838 tablets)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • IMU-838 tablets
  • Placebo matching IMU-838 tablets
  • Altamonte Springs, Florida
  • +28 more
Jul 29, 2022

MS Relapses During COVID-19 Pandemic

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • No Intervention
  • (no location specified)
Apr 22, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • serum Neurofilament Filament Light chain (sNfL) monitoring
  • Basel, Basel Stadt, Switzerland
  • +7 more
Oct 17, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Sweden (Rituximab)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Danderyd, Stockholm, Sweden
  • +16 more
Apr 15, 2021

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in West Hollywood (Dosing Interruption of Natalizumab)

Recruiting
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Dosing Interruption of Natalizumab
  • West Hollywood, California
    Regina Berkovich MD, PhD Inc.
Jul 20, 2021

Multiple Sclerosis Trial in Buffalo (repository corticotropin injection, Saline)

Withdrawn
  • Multiple Sclerosis
  • repository corticotropin injection
  • Saline
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Dec 30, 2020

Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • 23-PPV
  • +5 more
  • Cullman, Alabama
  • +21 more
Apr 4, 2022

Multiple Sclerosis (MS), Multiple Sclerosis (MS) Relapsing Remitting, Multiple Sclerosis (MS) Primary Progressive Trial in

Completed
  • Multiple Sclerosis (MS)
  • +6 more
  • Video-oculography / Social cognition tasks / Neuropsychological evaluations
  • Monaco, Monaco
    Centre Mémoire / Centre de Gérontologie Clinique Rainier III / P
Jan 19, 2021

Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Los Angeles, California
    University of Southern California
Feb 3, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Norway (dimethyl fumarate, injectable MS DMT)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • dimethyl fumarate
  • injectable MS DMT
  • Drammen, Norway
  • +6 more
Sep 3, 2021

Relapse Remitting Multiple Sclerosis Trial in Czechia, Ukraine, United States (VAY736, Placebo)

Terminated
Has Results
  • Relapse Remitting Multiple Sclerosis
  • Long Beach, California
  • +4 more
Dec 9, 2020

Relapses in Multiple Sclerosis (MS) and Vitamin D Intake

Completed
  • Multiple Sclerosis
    • Peoria, Illinois
      OSF Saint Francis Medical Center
    Apr 22, 2022

    Multiple Sclerosis Trial in Cairo (Blood sample collection)

    Recruiting
    • Multiple Sclerosis
    • Blood sample collection
    • Cairo, Egypt
      Nasser Institute for Research and Treatment
    Feb 21, 2023

    Patient Participation Trial in Pozzilli (Prebiotics and Probiotics supplementation, Placebo supplementation, peripheral blood

    Not yet recruiting
    • Patient Participation
    • Prebiotics and Probiotics supplementation
    • +3 more
    • Pozzilli, Isernia, Italy
      IRCCS INM-Neuromed
    Mar 9, 2023

    Relapsing Remitting Multiple Sclerosis, Fatigue, Cognitive Therapy Trial in Poissy (Behavorial Cognitive Therapy (BCT))

    Completed
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Behavorial Cognitive Therapy (BCT)
    • Poissy, France
      Poissy St Germain Hospital
    Mar 15, 2021

    Multiple Sclerosis, Relapsing-Remitting Trial in United States (Acthar Gel, Placebo)

    Terminated
    Has Results
    • Multiple Sclerosis, Relapsing-Remitting
    • Acthar Gel
    • Placebo
    • Palo Alto, California
    • +21 more
    Jun 14, 2021

    Diagnosis of ON With or Without MS or NMOSD

    Enrolling by invitation
    • Multiple Sclerosis
    • +4 more
    • Reflex (Brightlamp Inc., Purdue University)
    • Lexington, Kentucky
      University of Kentucky
    Apr 27, 2021

    Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis Trial in France (Perfusion of treatment Rituximab, Perfusion of

    Not yet recruiting
    • Multiple Sclerosis
    • Relapsing-remitting Multiple Sclerosis
    • Perfusion of treatment Rituximab
    • Perfusion of treatment Ocrelizumab
    • Lyon, Bron, France
    • +22 more
    Mar 6, 2023

    Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (GNbAC1, Placebo)

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • Sofia, Bulgaria
    • +11 more
    Oct 19, 2020

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Amsterdam (DMT)

    Recruiting
    • Multiple Sclerosis
    • +2 more
    • Amsterdam, Netherlands
      Amsterdam UMC
    Oct 13, 2020